Impaired insulin signaling and reduced responsiveness are implicated in Alzheimer's disease (AD), mild cognitive impairment (MCI), and other neurodegenerative conditions.3, 14. This evidence concerns the gene INS and early-onset autosomal dominant Alzheimer disease.